key: cord-0771425-hmc78tv3 authors: Finsterer, Josef; Scorza, Fulvio A title: Mental compromise in SARS-CoV-2 infected patients is multicausal, organic or inorganic date: 2021-09-22 journal: Brain Commun DOI: 10.1093/braincomms/fcab218 sha: 151f832b6f6f1fdbab5d24db28170d546aea3cc2 doc_id: 771425 cord_uid: hmc78tv3 nan neurological deficits [4] . Single patients with encephalitis and mania have been reported. Such patients may favourably respond to steroids or intravenous immunoglobulins, not only with regard to encephalitis but also with regard to the mental condition. Since mental disease in patients with SARS-CoV-2 infections may have a neurological origin, it is crucial that patients with mental compromise are thoroughly investigated for neurological causes of the psychological compromise. Work-up for neurological disease should not only include a profound individual and family history and a clinical neurologic exam but also imaging of the central nervous system and the vascular supply with contrast medium, EEG, and eventually investigations of the cerebro-spinal fluid. Assuming that SARS-CoV-2 infections are associated with neuronal or glial death, it is recommended that COVID-19 patients undergo appropriate neuropsychological testing on admission and on dismissal from the hospital. An issue not addressed in the review is that the anti-COVID-19 medication may be neurotoxic and may be responsible for long-term mental impairment in patients experiencing a SARS-CoV-2 infection. Particularly, from chloroquine it is known that it can cause severe psychiatric disease and some patients may even commit suicide [5] . In a single patient with COVID-19 the loading dose of favipiravir triggered an acute psychosis [6] . In a study on the side effects of tocilizumab given prior to haematopoetic stem cell transplantation, the prevalence of depression was significantly increased compared to controls [7] . From steroids, it is well-known that they may induce a drive increase, hallucinations, or even psychosis. From linezolid, it is known that it can cause serotonin syndrome [8] . As virus RNA has been repeatedly documented in neurons, glial cells, or the cerebro-spinal fluid [9] , pathways must exist along which the virus enters the brain. In this sense, SARS-CoV-2 may not only enter the brain via retrograde migration through axons of cranial nerves or the blood stream and directly crossing the BBB but also by incorporation into lymphocytes, which may achieve the ability to cross the blood-brain barrier together with the virus [10] . Assuming that SARS-CoV-2 causes chronic cerebral inflammation, one would expect pleocytosis, increased cerebro-spinal fluid protein, or positive oligoclonal bands. However, cerebro-spinal fluid abnormalities of this kind have been only reported in patients with neurological involvement in COVID-19. We do not agree with the notion that mental health compromise in SARS-CoV-2 infected patients is due to cerebral hypoxia. Patients with severe COVID-19 require oxygen supplementation or even mechanical ventilation. These patients are usually carefully monitored for sufficient oxygenation on an ICU and are not exposed to hypoxia. A further argument against hypoxia as the cause of mental disturbance is that patients with severe COVID-19 usually do not present with the classical stigmata of hypoxia on cerebral imaging. Hyposmia/anosmia and hypogeusia/ageusia may not only result from invasion of neurons but simply from the occupation of the taste buds of the tongue or the pharynx or the olfactory cells in the nasal epithelium by the virus. Concerning 'lymphohistiocytosis' it should be considered that COVID-19 patients may also experience lymphopenia. Overall, the review has several limitations which challenge the results and their interpretation. SARS-CoV-2 infected patients developing compromise of mental health require clinical and instrumental neurological work-up. Before attributing mental dysfunction to psychiatric involvement in the infection, central nervous system involvement with psychiatric presentation must be thoroughly excluded. To assess if mental health compromise has truly an organic background the brain needs to be extensively investigated. Central nervous system compromise from SARS-CoV-2 may be at variance from the pathophysiology in HIV encephalopathy or in Alzheimer's disease. Science should prevent hysteria from becoming more harmful than the virus. Neurological and mental health consequences of COVID-19: Potential implications for well-being and labour force Neurological consequences of SARS-CoV-2 infection and concurrence of treatmentinduced neuropsychiatric adverse events in COVID-19 patients: Navigating the uncharted COVID-19 post-infectious encephalitis presenting with delirium as an initial manifestation CoroNerve Study Management Group; et al. COVID-19 Encephalitis with SARS-CoV-2 detected in cerebrospinal fluid presenting as a stroke mimic Psychiatric disorders and hydroxychloroquine for coronavirus disease 2019 (COVID-19): A VigiBase study Acute psychosis in COVID-19: Is it due to favipiravir treatment or acute viral illness? The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically ill Linezolid-induced serotonin syndrome SARS-CoV-2 neuronal invasion and complications: Potential mechanisms and therapeutic approaches Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: A review The authors report no competing interests.